# BXP, Inc.: overview

BXP · NYSE · CIK 1037540 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bxp.md) · [Financials](/companies/bxp/financials.md) · [Filings](/companies/bxp/filings.md) · [Insiders](/companies/bxp/insiders.md)

Latest reported revenue: [$895.7m](/filings/0001037540-26-000034.md) for Q4 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001037540-26-000034).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [859](/filings/0001037540-25-000013.md) | [859 d](/filings/0001037540-26-000006.md) | [865](/filings/0001037540-26-000019.md) | [868](/filings/0001037540-26-000034.md) | [872](/filings/0001037540-25-000013.md) | [877 d](/filings/0001037540-26-000006.md) | [872](/filings/0001037540-26-000019.md) | [896](/filings/0001037540-26-000034.md) |
| Gross margin | % | [59.5%](/filings/0001037540-25-000013.md) | [59.7% d](/filings/0001037540-26-000006.md) | [59.2%](/filings/0001037540-26-000019.md) | [59.2%](/filings/0001037540-26-000034.md) | [59.3%](/filings/0001037540-25-000013.md) | [58.8% d](/filings/0001037540-26-000006.md) | [58.0%](/filings/0001037540-26-000019.md) | [60.1%](/filings/0001037540-26-000034.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [9.7%](/filings/0001037540-25-000013.md) | [(26.7%) d](/filings/0001037540-26-000006.md) | [7.1%](/filings/0001037540-26-000019.md) | [10.2%](/filings/0001037540-26-000034.md) | [(14.0%)](/filings/0001037540-25-000013.md) | [28.3% d](/filings/0001037540-26-000006.md) | [11.6%](/filings/0001037540-26-000019.md) | [7.7%](/filings/0001037540-26-000034.md) |
| Diluted EPS | $ per share | [0.53](/filings/0001037540-25-000013.md) | not reported | [0.39](/filings/0001037540-26-000019.md) | [0.56](/filings/0001037540-26-000034.md) | [(0.77)](/filings/0001037540-25-000013.md) | not reported | [0.64](/filings/0001037540-26-000019.md) | [0.43](/filings/0001037540-26-000034.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,889](/filings/0001656423-24-000007.md) | [3,109](/filings/0001656423-25-000009.md) | [3,274](/filings/0001037540-26-000006.md) | [3,408](/filings/0001037540-26-000006.md) | [3,482](/filings/0001037540-26-000006.md) |
| Gross margin | % | [62.8%](/filings/0001656423-24-000007.md) | [62.1%](/filings/0001656423-25-000009.md) | [61.1%](/filings/0001037540-26-000006.md) | [59.9%](/filings/0001037540-26-000006.md) | [59.1%](/filings/0001037540-26-000006.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [17.5%](/filings/0001656423-24-000007.md) | [27.3%](/filings/0001656423-25-000009.md) | [5.8%](/filings/0001037540-26-000006.md) | [0.4%](/filings/0001037540-26-000006.md) | [7.9%](/filings/0001037540-26-000006.md) |
| Diluted EPS | $ per share | [3.17](/filings/0001656423-24-000007.md) | [5.40](/filings/0001656423-25-000009.md) | [1.21](/filings/0001037540-26-000006.md) | [0.09](/filings/0001037540-26-000006.md) | [1.74](/filings/0001037540-26-000006.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bxp/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.19bn | 17,981,430 |  | Added +1,521,475 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $859.6m | 12,963,896 |  | Added +139,352 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $666.6m | 10,052,458 |  | Added +81,817 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $659.6m | 9,845,148 |  | Reduced −44,920 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $627.8m | 9,467,247 |  | Added +122,786 |
| [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $627.8m | 9,467,247 |  | Added +122,786 |
| [APG Asset Management US Inc.](/funds/1323255.md) | 2026-06-30 | $489.9m | 7,230,130 |  | Added +17,549 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $429.8m | 6,481,326 |  | New +6,481,326 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $384.6m | 5,799,416 |  | Reduced −460,269 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $291.0m | 4,395,853 |  | Added +82,880 |

## Recent filings

[All 2,025 filings](/companies/bxp/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:10 ET | [8-K](/filings/0001037540-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001037540-26-000041 |
| 2026-08-31 | 16:18 ET | [8-K](/filings/0001037540-26-000037.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001037540-26-000037 |
| 2026-08-06 | 14:17 ET | [10-Q](/filings/0001037540-26-000034.md) | Quarterly report, period 2026-06-30 | 0001037540-26-000034 |
| 2026-07-28 | 16:14 ET | [8-K](/filings/0001037540-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001037540-26-000031 |
| 2026-05-29 | 16:36 ET | [8-K](/filings/0001037540-26-000026.md) | 2.06 Material impairments; 9.01 Financial statements and exhibits | 0001037540-26-000026 |
| 2026-05-22 | 16:25 ET | [8-K](/filings/0001037540-26-000022.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001037540-26-000022 |
| 2026-05-07 | 16:10 ET | [10-Q](/filings/0001037540-26-000019.md) | Quarterly report, period 2026-03-31 | 0001037540-26-000019 |
| 2026-04-28 | 16:12 ET | [8-K](/filings/0001037540-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001037540-26-000015 |
| 2026-04-10 | 09:27 ET | [DEF 14A](/filings/0001037540-26-000010.md) | Proxy statement, period 2026-05-21 | 0001037540-26-000010 |
| 2026-03-06 | 17:28 ET | [8-K](/filings/0001193125-26-096974.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-096974 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001037540-26-000006.md), filed Feb 27, 2026.

## Forecast league

Q1 FY2027, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/b54ac72d-e768-49bb-a338-00f7ae5817c9)

## About the filer

- CIK: 1037540
- Tickers: BXP
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:13 ET. No prices; not investment advice.